[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:pancreatic-adenosquamous-carcinoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Pancreatic Adenosquamous Carcinoma",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04157127","Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma",[11],"Phase 1","RECRUITING","2026-08-26T02:18:38.865010Z","2026-05-05T02:43:29.366404Z",[],[]]